ClearPoint Neuro completed the acquisition of IRRAS.

ClearPoint Neuro, a global device, cell, and gene therapy-enabling company, completed the acquisition of IRRAS, a medical technology company. Financial terms were not disclosed. "This is a very strategic merger transaction for ClearPoint Neuro, and we believe this addition is complementary to our vision as we continue to become the world's premier neuro drug delivery partner for the biopharma community," Joe Burnett, ClearPoint Neuro President and CEO.